← Browse by Condition
Medical Condition

gastroesophageal junction

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06445972 Phase 1, Phase 2
Recruiting

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Enrollment
210 pts
Location
United States, Brazi...
Sponsor
Merck Sharp & Dohme LLC
View Trial →